Why the study?
A history of preoperative atrial fibrillation has been associated with unfavorable outcomes and loss of biventricular pacing in heart failure patients treated with CRT, but its impact on long-term outcomes needed assessment.
Does pre-procedural atrial fibrillation worsen outcomes (hospitalization due to HF or death) in heart failure patients treated with cardiac resynchronization therapy?
Cohort (n=118)
Does pre-procedural atrial fibrillation worsen outcomes (hospitalization due to HF or death) in heart failure patients treated with cardiac resynchronization therapy?
Answers are grounded in this paper and cite their sources.
Pre-procedural atrial fibrillation and lower biventricular pacing percentages are strong independent predictors of increased mortality and heart failure hospitalization in patients receiving cardiac resynchronization therapy.
Introduction A history of preoperative atrial fibrillation (AF) has been found to be associated with unfavorable outcomes, higher risks of non-response to cardiac resynchronization therapy (CRT) and loss of biventricular pacing (BivP). We aimed to assess the impact of AF and BivP on long-term outcomes in heart failure patients treated with CRT. Methods We retrospectively enrolled 227 patients undergoing CRT implantation between 2013 and 2020 according to the current guidelines. 118 patients were included in our analysis, from whom all data were available. Clinical, electrocardiographic and echocardiographic parameters were evaluated at baseline and 6 months after CRT. Response to CRT was defined as an increase in left ventricular ejection fraction (LVEF) >10%. We considered an effective delivery of BivP >98%. The primary endpoint was the composite endpoint of hospitalization due to HF or death for any cause. Results 118 patients were included (mean age 69±11 years, 66.1% males, 39.8% ischemic etiology; baseline LVEF was 27,6±6%). Patients were divided into AF (n=42; 35,6%) and sinus rhythm (SR (n=76); 18 patients had permanent AF. AF patients had higher index left atrial volume and left ventricular mass (p<0.001). Mean follow-up time was 43±18 months. BivP percentage was significantly superior in SR than in AF patients (98.1±2.1% vs 94.7±4.5%, p<0.001), with 75% of SR patients having BivP>98% vs 30,3% of AF patients (p<0.001). There were no differences in preoperative parameters between them. The response rate to CRT was higher in SR patients when compared to AF patients (63,2% vs 40,5%, p=0.021). Indeed, the variation of LVEF was higher in SR patients (12±10% vs 7±9%, p=0.012). During follow-up, there were significant differences between AF and SR patients in the primary endpoint (73,8% vs 42,6%, p<0.001), and mortality for any cause (26,2% vs 9,2% p=0.014; p<0.001). In a multivariate logistic regression analysis pre-procedural AF and BivP (%) were the only independent predictors of primary endpoint (HR 8.949, 95% CI 2.429 – 32.972, p=0.001; HR 0.719, 95% CI 0.526 – 0.982, p=0.038, respectively). Kaplan-Meier curves showed that event survival free was higher in SR patients when compared to AF (69±4 vs 24±3 months, p<0.001) Conclusion Pre - procedural AF and BivP are independent predictors of the occurrence of a primary endpoint of hospitalization due to HF or death for any cause in HF patients submitted to CRT.
No takes yet. Share an insight, caveat, or question.
Pereira et al. (2021) conducted a cohort in Heart failure treated with cardiac resynchronization therapy (CRT) (n=118). Pre-procedural atrial fibrillation vs. Sinus rhythm was evaluated on Composite endpoint of hospitalization due to HF or death for any cause (HR 8.949, 95% CI 2.429-32.972, p=0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: